Related Experiment Videos
The 1998 Nobel prize in Medicine: clinical implications for 1999 and beyond
Vascular Medicine (London, England)
|July 16, 1999
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Fatal herpes simplex virus hepatitis following neoadjuvant chemoradiotherapy and anterior resection for rectal cancer.
Annals of the Royal College of Surgeons of England·2014
Meal-induced increases in C-reactive protein, interleukin-6 and tumour necrosis factor α are attenuated by prandial + basal insulin in patients with Type 2 diabetes.
Diabetic medicine : a journal of the British Diabetic Association·2011
A pilot study of ranolazine in patients with intermittent claudication.
International angiology : a journal of the International Union of Angiology·2006
ADMA regulates angiogenesis: genetic and metabolic evidence.
Vascular medicine (London, England)·2005
Metformin treatment lowers asymmetric dimethylarginine concentrations in patients with type 2 diabetes.
Metabolism: clinical and experimental·2002
Proteinuria in a placebo-controlled study of basic fibroblast growth factor for intermittent claudication.
Vascular medicine (London, England)·2002
Normal endothelial peripheral arterial tonometry values in healthy children: A systematic review and meta-analysis.
Vascular medicine (London, England)·2026
Association of physical activity with arterial stiffness and pulsatility in a community-based cohort.
Vascular medicine (London, England)·2026
Impaired acute metabolic responses to submaximal exercise in peripheral artery disease (PAD).
Vascular medicine (London, England)·2026
Clonal hematopoiesis of indeterminate potential (CHIP), vascular somatic mutation, and cardiovascular disease: A narrative review.
Vascular medicine (London, England)·2026
Hemodialysis access in 2026: What the vascular medicine provider should know.
Vascular medicine (London, England)·2026
Predictors and clinical course of chronic limb-threatening ischemia with hemodynamic failure after endovascular therapy.
Vascular medicine (London, England)·2026
BMAL1 mediates venetoclax resistance in acute myeloid leukemia by interacting with TPD52.
Biochemical pharmacology·2026